NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Synthelis Biotech

Synthelis Biotech

Private
La TroncheHealthcare & Life Scienceshttps://synthelis.com/

Last Round

Grant

Dec 12, 2024

Total Funding Raised

$830,000

Company Overview

Synthelis Biotech is a biotechnology company that provides cell-free protein expression systems and bioluminescence solutions for pharmaceutical, biomedical, and academic research.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Biotech Equipment

Business Model

B2B

Customer Profile

Services & Consulting, Usage-Based SaaS

AI Layer

Application

Keywords

cell-free protein expressionprotein productionmembrane proteinsbioluminescent assaysrecombinant proteinsdrug discoverycontract research organizationCROprotein engineeringbiotech reagentsstructural biologylab automationin-silico protein designwet-lab servicesbiotech tools

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Synthelis Biotech Comps

Public and private peers based on sector, stage, and business model.

Synthelis Biotech comps — public and private peers by sector, stage, and business model
CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Synthelis Biotech Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
GrantDec 12, 2024
M&ANov 24, 2023
SeedJan 21, 2014

Key People

Founding team and executive leadership

Vincent Poher

Chief Executive Officer

Executive Team

Synthelis Biotech Investors

Notable investors and investment history

Synthelis Biotech investors
InvestorRounds
France 2030Grant
Grenoble AngelsSeed
KreaxiSeed
Savoie Mont Blanc AngelsSeed
BpifranceGrant

Synthelis Biotech Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Synthelis Biotech Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Synthelis Biotech's valuation, stock price, and market status.

Firmographic Details

HeadquartersLa Tronche
Employee Range13
Year Founded2011
Last FundingDec 12, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.